Tissue Regenix, the AIM listed regenerative medical devices company, has appointed David Cocke as Chief Financial Officer (CFO) and Director to the Board with immediate effect.
Mr Cocke has over 29 years of experience in the medical device industry holding senior finance and operations positions.
In 1997, he founded NuPak Medical, an ISO-certified contract manufacturer of sterile disposable medical devices, with the company turning cash flow positive in two years and growing the production volume from 50k to 3m over time.
NuPak Medical was acquired by Katena Products in 2017 and Mr Cocke remained with the business post-acquisition until early 2021, leading the expansion to double the clean room capacity and assembly space on-time and on-budget.
Mr Cocke was also Chief Financial Officer at Aperion Biologics from 2008-2017 and supported the Board in raising $21 million from venture capital and private investors.
Prior to this, he was Senior Director for Finance and Operations at Kinetic Concepts from 1993-1996.
“David is a well-respected finance professional in the medical device industry,” said Daniel Lee, CEO of Leeds-based Tissue Regenix.
“His experience of implementing financial systems and management as well as operations, will be invaluable to the Group as we undertake the next stages of our capacity expansion programme.
“Having worked with David previously at Aperion Biologics I have seen first-hand the value he brings to a business and I am happy to welcome him to the Tissue Regenix Group.”
